Chargement en cours...

High-Dose Galantamine Augmentation Inferior to Placebo on Attention, Inhibitory Control and Working Memory Performance in Nonsmokers with Schizophrenia

Dysfunction in the neuronal nicotinic acetylcholine receptor (nAChR) system has been implicated in the pathophysiology of schizophrenia, and it has been postulated that treatments that increase nAChR activity may improve symptoms of the disorder. We investigated the effects of the acetylcholinestera...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Dyer, Michael A., Freudenreich, Oliver, Culhane, Melissa A., Pachas, Gladys N., Deckersbach, Thilo, Murphy, Erin, Goff, Donald C., Evins, A. Eden
Format: Artigo
Langue:Inglês
Publié: 2008
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2596972/
https://ncbi.nlm.nih.gov/pubmed/18325740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.schres.2007.12.491
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!